daxxify

Generic: botulinum toxin type a

Labeler: revance therapeutics, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name daxxify
Generic Name botulinum toxin type a
Labeler revance therapeutics, inc.
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAMUSCULAR
Active Ingredients

botulinum toxin type a 100 U/1.2mL

Manufacturer
Revance Therapeutics, Inc.

Identifiers & Regulatory

Product NDC 72960-112
Product ID 72960-112_71c76e28-0eb6-487e-a53b-4c9e78021e57
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761127
Listing Expiration 2027-12-31
Marketing Start 2022-09-20

Pharmacologic Class

Established (EPC)
acetylcholine release inhibitor [epc] neuromuscular blocker [epc]
Mechanism of Action
acetylcholine release inhibitors [moa]
Physiologic Effect
neuromuscular blockade [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72960112
Hyphenated Format 72960-112

Supplemental Identifiers

RxCUI
2612454 2612456
UPC
0372960112018
UNII
E211KPY694
NUI
N0000175771 N0000193962 N0000175731 N0000175770

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name daxxify (source: ndc)
Generic Name botulinum toxin type a (source: ndc)
Application Number BLA761127 (source: ndc)
Routes
INTRAMUSCULAR
source: ndc

Resolved Composition

Strengths
  • 100 U/1.2mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-USE in 1 CARTON (72960-112-01) / 1.2 mL in 1 VIAL, SINGLE-USE
  • 1 VIAL, SINGLE-USE in 1 CARTON (72960-112-02) / 1.2 mL in 1 VIAL, SINGLE-USE
source: ndc

Packages (2)

72960-112-01 1 VIAL, SINGLE-USE in 1 CARTON (72960-112-01) / 1.2 mL in 1 VIAL, SINGLE-USE 72960-112-02 1 VIAL, SINGLE-USE in 1 CARTON (72960-112-02) / 1.2 mL in 1 VIAL, SINGLE-USE

Ingredients (1)

botulinum toxin type a (100 U/1.2mL)

Linked Drug Pages (1)

DAXXIFY ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR"], "spl_id": "71c76e28-0eb6-487e-a53b-4c9e78021e57", "openfda": {"nui": ["N0000175771", "N0000193962", "N0000175731", "N0000175770"], "upc": ["0372960112018"], "unii": ["E211KPY694"], "rxcui": ["2612454", "2612456"], "spl_set_id": ["3aaa6e14-a3f7-4fb2-b9f9-d3a9c3ae1f74"], "pharm_class_pe": ["Neuromuscular Blockade [PE]"], "pharm_class_epc": ["Acetylcholine Release Inhibitor [EPC]", "Neuromuscular Blocker [EPC]"], "pharm_class_moa": ["Acetylcholine Release Inhibitors [MoA]"], "manufacturer_name": ["Revance Therapeutics, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (72960-112-01)  / 1.2 mL in 1 VIAL, SINGLE-USE", "package_ndc": "72960-112-01", "marketing_start_date": "20220920"}, {"sample": true, "description": "1 VIAL, SINGLE-USE in 1 CARTON (72960-112-02)  / 1.2 mL in 1 VIAL, SINGLE-USE", "package_ndc": "72960-112-02", "marketing_start_date": "20220920"}], "brand_name": "DAXXIFY", "product_id": "72960-112_71c76e28-0eb6-487e-a53b-4c9e78021e57", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Acetylcholine Release Inhibitor [EPC]", "Acetylcholine Release Inhibitors [MoA]", "Neuromuscular Blockade [PE]", "Neuromuscular Blocker [EPC]"], "product_ndc": "72960-112", "generic_name": "botulinum toxin type A", "labeler_name": "Revance Therapeutics, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DAXXIFY", "active_ingredients": [{"name": "BOTULINUM TOXIN TYPE A", "strength": "100 U/1.2mL"}], "application_number": "BLA761127", "marketing_category": "BLA", "marketing_start_date": "20220920", "listing_expiration_date": "20271231"}